Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...
Oprah Winfrey recently detailed how taking weight loss drugs shifted her longtime mindset about what she described as “thin ...
Amycretin could give Novo a buzzy product in an newly competitive obesity market. It works similarly to existing GLP-1 ...
Novo Nordisk shares jumped on Friday as the Danish drugmaker said an experimental drug was able to reduce weight by as much ...
Novo Nordisk is currently leading the market for incretin therapies with semaglutide-based products Ozempic for type 2 ...
The author of a new guidebook on GLP-1s and other experts share their tips for how clinicians can optimize patient success ...
Novo Nordisk A/S rose the most in a month after an experimental shot delivered as much as 22% weight loss in an early-stage ...
Read about Tracy Morgan's weight loss journey and how he toned himself down. From diet to workout routine, know all about how ...
Colorado plans to limit insurance coverage for weight-loss drugs like Wegovy and Ozempic for thousands of state employees.
American doctors have now discovered the injections put users at 'significantly higher' risk compared to three other common diabetes drugs.
A Medscape survey found that a strong majority of physicians believe high-risk patients should have easier access to new weight loss drugs.